Bespoke Extracts (BSPK) Cash & Equivalents (2011 - 2025)

Bespoke Extracts has disclosed Cash & Equivalents across 15 years of filings, most recently posting $16743.0 for Q3 2025.

• Cash & Equivalents for Q3 2025 came in at $16743.0, down 21.93% year-over-year; the trailing twelve-month figure through Sep 2025 was $16743.0 (down 21.93% YoY), and the FY2024 annual result was $60305.0, up 812.74% from the prior year.
• Cash & Equivalents came in at $16743.0 for Q3 2025 at Bespoke Extracts, up from $1363.0 in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $501560.0 in Q1 2021 to a low of $1363.0 in Q2 2025.
• The 5-year median for Cash & Equivalents is $19094.0 (2024), against an average of $52151.0.
• Peak annual rise in Cash & Equivalents reached 27522.92% in 2021, while the deepest fall reached 97.56% in 2021.
• Bespoke Extracts' Cash & Equivalents stood at $6295.0 in 2021, then jumped by 288.13% to $24433.0 in 2022, then slumped by 72.96% to $6607.0 in 2023, then soared by 812.74% to $60305.0 in 2024, then sank by 72.24% to $16743.0 in 2025.
• The last three Cash & Equivalents figures came in at $16743.0 (Q3 2025), $1363.0 (Q2 2025), and $30365.0 (Q1 2025), per Business Quant data.